CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1993; 43:327
doi: 10.3322/canjclin.43.6.327
© 1993 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinshel, E. L.
Right arrow Articles by Peterson, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinshel, E. L.
Right arrow Articles by Peterson, B. A.

CA: A Cancer Journal for Clinicians, Vol 43, Issue 6 327-346, Copyright © 1993 by American Cancer Society

ARTICLES

Hodgkin's disease

E. L. Weinshel and B. A. Peterson
Division of Medical Oncology, University of Minnesota Medical School, Minneapolis.

The etiology of Hodgkin's disease is unknown, and the identity of the normal counterpart of the malignant cell involved in Hodgkin's disease remains controversial. Yet, three of every four patients diagnosed with Hodgkin's disease will be cured. This success in treatment is due in large part to the application of modern oncologic techniques, such as combination chemotherapy and the use of staging to guide therapy. This article reviews important advances in the understanding and treatment of Hodgkin's disease.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by American Cancer Society.